Recent Developments in the Synthesis and Applications of Anticancer Amonafide Derivatives. A Mini Review

Author(s): Gary Gellerman.

Journal Name: Letters in Drug Design & Discovery

Volume 13 , Issue 1 , 2016

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Among anticancer DNA-intercalating agents, medicinally important 1,8-naphthalimide derivatives represent an important class of bioleads possessed substantial cytotoxic activity toward a variety of murine and human cancercells. Amonafide, as the representative of this family, plays an important role due to its potent antitumor properties. Amonafide is a topoisomerase II (Topo II) inhibitor and DNA intercalator that induces apoptosis by inhibiting the binding of Topo II to the double strand DNA and also preserves anticancer activity even in the presence of multi-drug resistance (MDR), a main contributor to adjuvant therapeutic failure. In this review are summarized recent developments in the synthesis of amonafide derivatives and their bioactivity. In addition, the effect of structural characteristicsof such agents on structure activity relationship (SAR) will be also discussed.

Keywords: Amonafide, addition-elimination, electrophilic aromatic substitution nucleophilic substitution, one-pot synthesis, dual function, anticancer.

Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 13
ISSUE: 1
Year: 2016
Page: [47 - 63]
Pages: 17
DOI: 10.2174/1570180812666150529205049

Article Metrics

PDF: 39
HTML: 5